mice lack all tissue angiotensin-converting enzyme (ACE) but have 33% of normal plasma ACE activity. They exhibit the urine-concentrating defect and hyperkalemia present in mice that lack all ACE, but in contrast to the complete knockout, ACE.2 mice have normal medullary histology and creatinine clearance. To explore the urine-concentrating defect in ACE.2 mice, renal medullary transport proteins were analyzed using Western blot analysis. In the inner medulla, UT-A1, ClC-K1, and aquaporin-1 (AQP1) were significantly reduced to 28 Ϯ 5, 6 Ϯ 6, and 39 Ϯ 5% of the level in wild-type mice, respectively, whereas AQP2 and UT-B were unchanged. In the outer medulla, Na
In the outer medulla, the thick ascending limb of the loops of Henle actively reabsorb NaCl, thereby diluting the luminal fluid and providing NaCl to increase the osmolality of the medullary interstitium. NaCl is reabsorbed by the action of the Na ϩ -K ϩ -2Cl Ϫ cotransporter (NKCC2/BSC1) in the apical membrane of the thick ascending limb and the sodium pump (Na ϩ -K ϩ -ATPase) in the basolateral membrane; the reabsorbed potassium is secreted back into the thick ascending limb lumen by the renal outer medullary potassium channel (ROMK) Kir 1.1 (reviewed in Refs. 8, 9, and 35) .
In the inner medulla, osmolality continues to increase from the inner-outer medullary border to the papillary tip. Although the precise mechanism by which this occurs remains controversial, the most widely accepted mechanism remains the passive mechanism hypothesis proposed in 1972 by Kokko and Rector (14) and by Stephenson (32) . The passive mechanism hypothesis proposes that NaCl can be reabsorbed passively from the thin ascending limb of the loops of Henle because the inner medullary interstitium has a lower NaCl concentration, but a higher urea concentration, than fluid within its lumen. This permits NaCl to be reabsorbed from the thin ascending limb down its concentration gradient. Chloride is reabsorbed by the chloride channel, ClC-K1, in the thin ascending limb; the molecular mechanism for sodium reabsorption is unknown (reviewed in Ref. 30) .
The passive mechanism also requires a very high urea concentration within the inner medullary interstitial fluid to balance the higher NaCl concentration in the lumen of the thin ascending limb. The source of this urea is reabsorption from the terminal inner medullary collecting duct (IMCD; reviewed in Refs. 28 and 31) . The countercurrent configuration of nephron segments and vessels allows the generation of a medullary osmolality gradient along the corticomedullary axis. In the presence of a hypertonic medulla and vasopressin [AVP; also called antidiuretic hormone (ADH)], the entire collecting duct becomes highly permeable to water due to the insertion of aquaporin-2 (AQP2) water channels into the apical membrane (reviewed in Ref.
23), water is reabsorbed, and a concentrated urine is produced.
Several studies have documented that knockout mice with a genetic lack of angiotensinogen, angiotensin-converting enzyme (ACE), or both angiotensin type 1a (AT 1a ) and 1b (AT 1b ) receptors have a urine-concentrating defect due, in part, to a marked underdevelopment of the renal medulla (reviewed in Ref. 5) . Previously, we described a mouse, termed ACE.2, in which homologous recombination in embryonic stem cells resulted in an animal expressing a truncated form of ACE (7) . This protein, while catalytic, lacks the COOHterminal domain necessary for ACE incorporation into cell membranes. Thus ACE.2 mice have no tissue ACE and very low angiotensin II levels but possess ϳ33% of normal circulating (plasma) levels of ACE (7). While ACE.2 mice have a very low blood pressure, equivalent to that of mice lacking all ACE, light microscopy shows that they typically have normal development of the renal medulla (7) . ACE null mice have some degree of renal insufficiency, as indicated by an elevation of serum creatinine, but ACE.2 mice have serum creatinine and creatinine clearance values that are indistinguishable from wild-type littermate control mice (7) . Despite normal renal histology and renal function, ACE.2 mice have a profound urine-concentrating defect, equivalent to that present in mice lacking all ACE expression (7) . To gain insight into the molecular basis for the urine-concentrating defect in the ACE.2 mice, we measured the abundance of several of the major solute and water transport proteins in the renal inner and outer medulla.
METHODS
ACE.2 knockout mice. ACE.2 knockout mice were generated using targeted homologous recombination as previously described (7) . The mice used in this study were from the fifth and sixth generations of backcrossing onto a C57BL/6 background; wild-type littermates were used as controls (7) . In addition, mice were backcrossed onto a Swiss background (Taconic, Germantown, NY). The genotype of the mice was confirmed by standard PCR analysis. Blood was drawn by cardiac puncture at the time of death and assayed for sodium, potassium, chloride, and bicarbonate by the Emory University Pathology Department Clinical Laboratory.
Urine-concentrating ability. ACE.2 and wild-type mice were water deprived for 24 h but given food ad libitum. Urine was collected during this 24-h period and assayed for creatinine, sodium, potassium, chloride, and pH by the Emory University Pathology Department Clinical Laboratory. At the end of the 24-h period, a spot urine was collected and its osmolality was measured using a vapor pressure osmometer (model 5500, Wescor, Logan, UT). The mice were allowed to rehydrate for 3 wk before death.
Angiotensin II infusion. Angiotensin II (0.5 mg ⅐ kg Ϫ1 ⅐ day Ϫ1 dissolved in sterile 0.9% saline) or vehicle (saline) was infused via osmotic minipump into ACE.2 and wild-type mice for 2 wk (2). Blood pressure was measured by tail cuff as previously described (2) . Two days before death, a spot urine sample was collected to measure osmolality, and then the mice were water restricted for 8 h, after which a second spot urine sample was collected for osmolality measurement. The mice were allowed to rehydrate for 48 h before death. Blood Values are means Ϯ SE; n ϭ 11 wild-type and 13 ACE.2 knockout mice.
was collected at death, and aldosterone was measured using a radioimmunoassay (Diagnostic Products, Los Angeles, CA).
Preparation of kidney samples. Kidneys from ACE.2 and wild-type mice were dissected into cortex, outer medulla, and inner medulla as described (21), except that the inner medulla was not subdivided into base and tip portions due to the small size of the inner medulla in mice. Tissues from both kidneys of a single mouse were pooled and placed into icecold isolation buffer (10 mM triethanolamine, 250 mM sucrose, 1 g/ml leupeptin, 0.1 mg/ml PMSF, pH 7.6, 0.025-0.1 g tissue/ml isolation buffer), homogenized, sheared with a 26-gauge needle, and diluted 1:1 with 1% SDS for Western blot analysis of total cell lysate. Total protein in each sample was measured by the Bradford method (DC Protein Assay Kit, Bio-Rad, Richmond, CA).
Western blot analysis. Proteins (10 g/lane, except 30 g/ lane for ClC-K1) were size separated by SDS-PAGE using 7.5, 10, or 12% polyacrylamide gels. Proteins were blotted to polyvinylidene difluoride membranes (Gelman Scientific, Ann Arbor, MI). Blots were blocked with 5% nonfat dry milk in Tris-buffered saline (TBS; 20 mM Tris ⅐ HCl, 0.5 M NaCl, pH 7.5) at room temperature for 30 min, then incubated with primary antibody overnight at 4°C. Blots were washed three times in TBS with 0.5% Tween 20 (TBS/Tween) and then incubated with horseradish peroxidase-linked goat anti-rabbit IgG at a dilution of 1:4,000-1:5,000 (Amersham, Arlington Heights, IL) for 2 h at room temperature. Blots were washed twice with TBS/Tween, and then the bound secondary antibody was visualized using chemiluminescence (ECL kit, Amersham). Blots were quantified using an Imaging Densitometer GS670 and Molecular Analyst software (BioRad Laboratories, Hercules, CA). In all cases, parallel gels were stained with Coomassie blue and showed uniformity of loading (data not shown). Results are expressed as arbitrary units per microgram protein loaded.
Antibodies. Western blots were probed with antibodies (diluted in TBS/Tween) to the following proteins: NKCC2/ BSC1 (generous gift of Dr. B. K. Kishore, Univ. of Utah) (4, 11); ␣-1 subunit of Na-K-ATPase (Upstate Biotechnologies, Lake Placid, NY) (22) Statistics. Data are presented as means Ϯ SE, and n is the number of mice. An unpaired Student's t-test was used to test for statistical significance, with P Ͻ 0.05 indicating statistical significance.
RESULTS
Blood and urine chemistries. Serum potassium was significantly higher in ACE.2 than wild-type mice (Table 1). There was no difference in serum sodium, chloride, or bicarbonate (Table 1) . To verify that the ACE.2 mice in this study had a urine-concentrating defect (7), we measured urine osmolality after water deprivation. Maximal urine osmolality was significantly lower in the ACE.2 mice (1,020 Ϯ 10 mosmol/kgH 2 O) than in the wild-type mice (3,300 Ϯ 10 mosmol/kgH 2 O, Table  2 ). Urine volume and urine potassium excretion were significantly increased, and urine pH was significantly more acidic in the ACE.2 mice, compared with wildtype mice (Table 2) . Urine creatinine, sodium, and chloride excretion were similar in wild-type and ACE.2 mice (Table 2) .
Inner medulla. In ACE.2 mice, the protein abundances of the 117-kDa urea transporter UT-A1 (Fig. 1) , ClC-K1, the ϳ80-kDa chloride channel (Fig. 2) , and AQP1 (Fig. 3) were significantly reduced to 28 Ϯ 5, 6 Ϯ 6, and 39 Ϯ 5%, respectively, of the levels in wild-type mice. The protein, abundances of the 97-kDa UT-A1 protein (Fig. 1) , the water channel AQP2 (Fig. 4) , and the urea transporter UT-B (Fig. 5) were not different between kidneys from ACE.2 and wild-type mice.
Outer medulla. In ACE.2 mice, the protein abundances of NKCC2/BSC1, the Na (Fig. 6) , and the AQP1 water channel (Fig. 3) were significantly reduced to 56 Ϯ 11 and 29 Ϯ 6% of the level in wild-type mice, respectively. However, the protein abundances of the ␣-1 subunit of Na ϩ -K ϩ -ATPase (Fig. 7) , UT-A2 (Fig. 8) , UT-B (Fig. 5) , and AQP2 (Fig. 4) were not different between kidneys from ACE.2 and wild-type mice.
In marked contrast, the protein abundance of ROMK (Fig. 9 ) was significantly increased in ACE.2 mice to 711 Ϯ 187% of the level in wild-type mice. The identity of the 70-kDa band that is consistently detected by this antibody is unknown (3).
Cortex. The abundance of AQP1 and AQP2 proteins was not significantly different between kidneys from ACE.2 and wild-type mice (data not shown).
Swiss background. To ensure that the preceding changes were due to the ACE.2 knockout rather than the C57BL/6 background, we repeated these studies using ACE.2 mice bred onto a Swiss background (n ϭ 7 wild-type and 7 knockout mice). All of the results in the Swiss mice were the same as in C57BL/6 mice (data not shown).
Angiotensin II infusion. To determine whether the preceding changes could be rescued by angiotensin II infusion, minipumps with angiotensin II or vehicle were implanted into ACE.2 mice bred onto the C57BL/6 and Swiss backgrounds. Angiotensin II increased blood pressure and plasma aldosterone (vehicle: 1.9 Ϯ 0.3 nM; angiotensin II: 5.2 Ϯ 0.7 nM, n ϭ 4, P Ͻ 0.01) in the ACE.2 mice, indicating that the pumps worked correctly but had no effect on urine osmolality or the abundance of any transport protein (data not shown).
DISCUSSION
The major finding of this study is that the abundances of several major solute transport proteins responsible for generating a hypertonic medullary interstitium and of those of the AQP1 water channel are significantly decreased in genetically engineered mice that lack tissue ACE. These effects are independent of background (C57BL/6 vs. Swiss), strongly suggesting that the changes are a specific result of ACE.2 knock- out. In addition, the changes in urine osmolality and transporter protein abundances are not corrected by angiotensin II infusion, suggesting that angiotensin II administration to adult ACE.2 mice does not rescue these phenotypic features.
The marked (Ͼ80%) decreases in UT-A1 and ClC-K1 in ACE.2 mice could contribute to the urine-concentrating defect by reducing the amount of urea reabsorbed from the terminal inner medullary collecting duct and NaCl reabsorption from the thin ascending limb, respectively, thereby reducing the inner medullary contribution of these osmotically active solutes to the generation of a hypertonic medullary interstitium. The modest decrease in NKCC2/BSC1 may also contribute to the concentrating defect by reducing NaCl reabsorption from the thick ascending limb. The decrease in AQP1 may reduce water transport across the thin descending limb and descending vasa recta (1, 26) . Although we measured protein abundance in this study, rather than transport by perfused tubule, we and others have found an excellent correlation between the abundance of solute and water transporter proteins by Western blot analysis and transport as measured in isolated perfused kidney tubules (reviewed in Refs. 13, 23, and 28) . While it is tempting to conclude that the urine-concentrating defect in these ACE.2 mice results from the decrease in the abundance of these transport proteins, especially in the inner medulla, the present studies can only establish associations between changes in transporter abundance and the urine-concentrating defect rather than establishing a direct cause-and-effect relationship.
Inner medulla. According to the passive mechanism hypothesis (14, 32) , the production of concentrated urine in the inner medulla requires the delivery of large quantities of urea to the inner medullary interstitium to establish the chemical gradients necessary for passive NaCl reabsorption from the thin ascending limb. We have shown that urea reabsorption from the terminal IMCD is the source of urea for delivery to the inner medullary interstitium (29) . The UT-A1 urea transporter is expressed only in the apical membrane of the IMCD (24) . Thus the large decrease in UT-A1 protein could contribute to the urine-concentrating defect by reducing urea delivery to the inner medullary interstitium.
In normal rats, angiotensin II (in the presence of vasopressin) increases the phosphorylation of UT-A1 and urea permeability in perfused terminal IMCDs (10) . Thus the lack of angiotensin II in the ACE.2 mice may also result in submaximal function of the small amount of UT-A1 protein that is present in their inner medulla.
ClC-K1 is normally expressed in the thin ascending limb and is responsible for chloride reabsorption (16) . ClC-K1 is important for producing concentrated urine, because knockout mice that lack ClC-K1 (Clcnk1 mice) have a severe urine-concentrating defect, and treating these mice with vasopressin does not improve urineconcentrating ability (19) . The magnitude of the urineconcentrating defect in the ACE.2 mice and the Clcnk1 mice is very similar, suggesting that the Ͼ90% decrease in ClC-K1 protein in the ACE.2 mice may be the major cause of their concentrating defect.
AQP1 is normally expressed in the thin descending limb and descending vasa recta and is responsible for water transport (1, 26) . AQP1 is important for producing concentrated urine, because knockout mice that lack AQP1 have a severe urine-concentrating defect (18) . The two-thirds reduction in AQP1 protein in both the outer and inner medulla may contribute to the urine-concentrating defect in the ACE.2 mice.
Another surprising finding was the lack of change in AQP2, because AQP2 protein abundance is generally reduced when urine-concentrating ability is reduced (reviewed in Ref. 23) . Although the reabsorption of sodium and urea is crucial to the production of a hypertonic medulla, the excretion of concentrated urine requires the reabsorption of water (in excess of solute). The present study does not address whether ACE.2 mice have an abnormality in the regulated trafficking of AQP2, despite normal AQP2 protein abundance, nor whether there is a change in the abundance of AQP3 or AQP4 (located in the basolateral membrane of the collecting duct), and future studies will be needed to test these possibilities.
Outer medulla. NKCC2/BSC1 is expressed only in the apical membrane of the thick ascending limb (20) .
In combination with Na ϩ -K ϩ -ATPase in the basolateral membrane, NKCC2/BSC1 contributes to the active NaCl reabsorption that is needed to generate a hypertonic medullary interstitium (reviewed in Refs. 9 and 13). Knepper and colleagues (36) recently showed that NKCC2/BSC1 protein is decreased in hypercalcemic rats to 36% of control values in the inner stripe of the outer medulla and concluded that this reduction in NKCC2/BSC1 contributes to the concentrating defect in hypercalcemia (36) . In this study, we found that NKCC2/BSC1 protein was reduced to 56% of the level in wild-type mice in whole outer medulla. The decrease in NKCC2/BSC1 does not appear to result from nonspecific damage to the thick ascending limb, because neither we (present study) nor Knepper and colleagues (36) found a change in the abundance of the ␣-1 subunit of Na ϩ -K ϩ -ATPase that would occur if there were cell damage. Although the decrease in NKCC2/BSC1 protein is modest compared with the changes in UT-A1 and ClC-K1 in the inner medulla, it is similar to the decrease in NKCC2/BSC1 (and urine osmolality) in hypercalcemic rats (36) , suggesting that the decrease in NKCC2/BSC1 may also contribute to the urineconcentrating defect in the ACE.2 mice.
ROMK is expressed in the apical membrane of the thick ascending limb and is responsible for secreting K ϩ into the thick ascending limb lumen (15, 17) , where it is needed to establish the appropriate electrochemical gradients for NaCl reabsorption by NKCC2/BSC1 (reviewed in Refs. 8 and 27) . In contrast to the decrease in ROMK protein in hypercalcemic rats (36), we found a large increase in ROMK in the outer medulla of ACE.2 mice, regardless of background strain. Consistent with previous studies of ACE knockout mice (6), the ACE.2 mice in this study have mild hyperkalemia, elevated urinary potassium excretion, and low, but measurable, plasma aldosterone levels. This suggests that some hyperkalemia is necessary to stimulate angiotensin II-independent aldosterone secretion. However, how ACE knockout mice are able to maintain hyperkalemia despite an increase in urinary potassium excretion is unknown. One possibility is dietary potassium, because placing angiotensinogen knockout mice on a potassium-restricted diet is lethal (5, 25) . Because an increase in ROMK, coupled with a decrease in NKCC2/BSC1, could contribute to an increase in urinary potassium excretion, we speculate that the increase in ROMK protein in the outer medulla could be important for preventing lethal levels of hyperkalemia while permitting serum potassium to be high enough to stimulate some aldosterone secretion. Future studies will be necessary to elucidate the potassium homeostatic mechanisms present in ACE knockout mice.
In summary, ACE.2 mice have decreased abundance of UT-A1, ClC-K1, NKCC2/BSC1, and AQP1 proteins, which could contribute to the urine-concentrating defect by reducing urea delivery to the inner medullary interstitium, NaCl reabsorption from the thin and thick ascending limbs, and water transport across the thin descending limb and vasa recta, respectively. We conclude that the urine-concentrating defect in ACE.2 mice is associated with, and may result from, downregulation of some or all of these key transport proteins.
